Overview
Hanma Investment Group Co., Ltd. (HMI Group) is committed to "promoting the industrial revolution of biomass instead of minerals and becoming the world leader in comprehensive application of hemp industry!" . As a leading international and domestic industry leader, HMI Group opposes the legalization of all forms of recreational hemp. Over the years, HMI Group has made positive contributions to legally promoting the vigorous development of industrial and medical use of hemp industry in China, and has made great achievements in setting industry standards and norms. At present, HMI Group is a legal investment group in China, which is based on the whole industrial chain layout of industrial hemp and oriented towards biopharmaceuticals.
As a unicorn in this industry, HMI Group focuses on the whole industrial chain investment of industrial hemp, and carries out breeding, planting, extraction, R&D, production and sales worldwide. The industry covers biopharmaceuticals, food, health products, beauty cosmetics, medical devices, textiles, new materials and many other fields. At the same time, HMI Group has continuously deepened its industry analysis and industrial layout, actively carried out technology and product iteration, devoted itself to researching and implementing the "patent pool" strategy, strengthened the creation and application of intellectual property rights, expanded its social influence by setting up a media information platform, effectively built a global product sales network, and steadily entered the global market.
HMI Group has built an interdependent and mutually beneficial upstream and downstream industrial value chain for the comprehensive utilization of hemp plants.
In the field of breeding and planting, Yunnan Suma Biotechnology Co., Ltd. and Heilongjiang Hanzheng Hemp Technology Co., Ltd. were invested and established, and the Industrial Hemp Planting License issued by the Public Security Department was obtained. HMI Group, together with hemp research institute of Chinese Academy of Agricultural Sciences, Heilongjiang Academy of Sciences and other scientific research units, set up demonstration bases for medical hemp and fiber hemp breeding in Yunnan and Heilongjiang provinces, actively advocated the construction of "National Hemp Germplasm Gene Bank", collected the germplasm resources of hemp plants and their related wild plants, and laid a foundation for cultivating hemp varieties that meet China's industrial management policies and industrial standards and promoting their application. At present, the fiber hemp variety "Hemp No.1" has obtained the Crop Variety Registration Certificate in Heilongjiang Province, and the cultivated area has exceeded 100,000 mu. The medical hemp variety "Hemp No.1" with high content of cannabidiol has entered the breeding stage.
In terms of raw material extraction of medical hemp, Yunnan Hansu Biotechnology Co., Ltd. (referred to as HSBT ), a subsidiary of HMI Group, In terms of raw material extraction of medical hemp, Yunnan Hansu Biotechnology Co., Ltd. (referred to as HSBT ), a subsidiary of HMI Group, invested in Kunming to build a large-scale industrial hemp bio-extraction and separation base according to GMP standards. It passed the acceptance of various administrative departments and the Anti-drug Bureau of the Provincial Public Security Department and obtained the Industrial Hemp Mosaic Processing License. By using alcohol-soluble fluid crystallization technology, Hanbitol, a non-psychoactive component of cannabidiol (CBD), which has positive significance and far-reaching influence on medical and health industries, was extracted and separated from industrial hemp leaves. At present, this base is the world's single cannabidiol and other cannabinoids extraction factory, which can extract and separate a variety of effective components without psychoactive activities, and it is also the world's factory that can industrially extract geranyl flavone A from hemp. The extraction of pharmaceutical raw materials from hemp, a technological route that had never been tried before, was finally succeeded by HSBT, which became an industry benchmark and a demonstration project of Yunnan Anti-drug Bureau.
The extraction plant of HMI Group invested and built in Nevada, USA, has obtained the breeding, planting and extraction license issued by the U.S. government, and is located in Las Vegas. The layout of China and the United States has made the biopharmaceutical preparation technology of Hansu Biotech internationalized. Next, HMI Group will participate in the medical hemp industry investment in Canada at the invitation of the Canadian government, and the global industrialization layout in Britain, Australia and Japan has already begun.
HSBT pays attention to expanding the domestic and international markets, and the completion of the extraction and separation base has provided reliable raw materials and technological guarantee for exploring and overcoming intractable diseases such as cancer, Parkinson's disease, Alzheimer's disease, depression and epilepsy, and laid a foundation for future biopharmaceuticals. At present, Meirui Health (stock code: HK02327), a Hong Kong-listed company, has invested 25.55% of HSBT.
HMI Group, which has the full license of industrial hemp and the resources of core varieties, has set up Hanyi Biotechnology (Beijing) Co., Ltd. (HYBT) in order to serve the national big health strategy. HYBT is a biopharmaceutical enterprise mainly engaged in cannabinoid-based drug research, drug development and commercial operation. It has been recognized as Beijing High-tech Enterprise, Zhongguancun High-tech Enterprise, Beijing Science and Technology Small and Medium-sized Enterprise, Zhongguancun Gazelle Enterprise from 2020 to 2021, and Beijing Patent Pilot Unit by the national authorities.
As an R&D-driven enterprise, HYBT has established a leading platform for all-round research and development of cannabinoids. In 2017, it also established "Academician Expert Workstation" in cooperation with Academician Yang Baofeng, an academician of Chinese Academy of Engineering and a famous pharmacology expert. It is dedicated to the research on the correlation between the material basis and activity of industrial hemp, and further explores and explores the application of high value-added components in industrial hemp plants in the field of biopharmaceuticals. At present, medicinal research on cannabinoids has been carried out in key areas such as anti-epilepsy, anti-pulmonary hypertension, anti-depression, anti-Alzheimer's disease, anti-pancreatic cancer, anti-Parkinson's disease and rare diseases, and staged progress has been made. Among them, the "Ten Diseases and Ten Drugs" project funded by Beijing Municipal Science and Technology Commission-the new anti-epileptic drug hemp Polyphenol Soft Capsule project has completed the preclinical research. In addition, fruitful results have been achieved in the field of cannabinoid application technology. The self-developed extraction technology of nontoxic active ingredients of industrial hemp has obtained international patents and has been successfully applied to industrial production. The successful water-soluble technology of cannabidiol has significantly improved the bioavailability of cannabidiol. The successful atomization technology of cannabinoids and the ongoing transdermal drug delivery technology will greatly broaden the application scenarios of industrial hemp.
With cannabinoid drug development as the core, HYBT has actively carried out original research work, and applied for more than 100 patents at home and abroad in cannabinoid new drug research and applied technology development, and have grown into a biopharmaceutical company in a fast-developing track. HYBT has set up a platform for R&D and sales of food and health products, and signed an agreement with Canadian hemp Full License Company to set up a joint venture pet products company to develop and sell a series of products such as pet health products, snacks, hair care, etc., and strive to quickly transform non-pharmaceutical technical achievements into fast-moving consumer goods such as food and health products and pet products, thus providing a strong cash flow support for enterprises' continuous investment in pharmaceutical R&D, technology iteration and other scientific research. HMI Group has reached joint ventures or cooperation with many industry leaders and listed companies, and the downstream industries have entered the stage of value export.
Hemp Group insists on "scientific and technological innovation" as the core driving force, and accelerates the radiation development base in an all-round way, so as to realize the group's "globalization strategy". Adhering to the spirit of deep cultivation in the industry, Hemp Group will continue to explore in the fields of biopharmaceuticals and life sciences, and inject new vitality into the economic development engine of the national health industry.
Our mission: to promote the industrial revolution of biomass instead of minerals.
Our vision: to be a world leader in comprehensive application of hemp industry.
Our core values: an industry, a lifelong career!
Group Structure
OUR MISSION
Promote the industrial revolution of biomass to replace minerals.
OUR VISION
To become the world leader in the hemp industry.
CORE VALUE
A hemp industry, a lifetime career!
05 /
The technology innovation strategic alliance of national high value special biological resources industry was established in Beijing.
04.27 /
Strategic cooperation agreement with Heilongjiang Academy of Sciences.
05.08 /
Certificate of registration of crop varieties in Heilongjiang Province.
07.03 /
MWA Group was established, focusing on "industrial hemp, cultural media, Internet technology", the three major strategic investment area layout.
07.23-07.26 /
The technology innovation strategic alliance of national high value special biological resources industry council, i.e. Hemp Industry Seminar.
09.15 /
Participate in the "national high value special biological, i.e. hemp harvest ceremony.
12.21 /
The Academician Mr. Yang baofeng visited Group to discuss matters of transformation of scientific and technological products.
01.20 /
Obtain the patent right of "a kind of hemp antibacterial liquid and its preparation method and application".
04.09 /
The 2016 Global launch event of the relaxing drink SUTIWA.
06.02 /
SUTIWA was designated as the official drink in the 2016 Asia Pacific Economic Cooperation High Level Forum.
06.15 /
Organized the Association of Sino-Russian Medical Universities Council Meeting and Academic Conference in Beijing. The Group was invited to participate in China International New Material Industry Expo and the 27th Harbin International Economic and Trade Fair.
08.11 /
The strategic cooperation agreement was signed between the Group and Harbin Medical University.
09.09 /
Water Foundation of the Group has been identified as charitable organizations.
10.10 /
The Group was invited to attend the 1st Chinese Agricultural (Boao) Forum.
11.09 /
The Group and China National Research Institute of Food & Fermentation Industries reached a strategic alliance officially.
11.14 /
The Group set up overseas branch company in Las Vegas of USA.
11.15 /
Yunnan Hempsoul Bio-technology Co. Ltd., subsidiary company of HMI Group, has built in Kunming the industrial hemp plant extraction factory in China .
11.25 /
The opening ceremony of Yunnan Hempsoul industrial hemp extraction factory--the industrial hemp extraction factory in China.
01.15 /
Organized the Association of Sino-Russian Medical Universities Council Meeting and Academic Conference in Beijing.
03.20 /
CN PEOPLE made an exclusive report about Mr. Tan Xin, the president of HMI Group.
03.28 /
Beijing Science and Technology Association awarded a plaque of the "Academician Expert Workstation" to Hanyi Biology, the Academician Workstation of Mr. Yang Baofeng, President of Harbin Medical University.
04.24 /
HMI Group and Hunan Huasheng Group (stock code: 600156) entered into the field of hemp fiber spinning and weaving through strategic cooperation.
05.25 /
HMI Group was invited to participate in the "Second Science and Technology Diplomat Innovation Resource Docking Activity" of the Ministry of Science and Technology, and reported the new trend of China's industrial hemp industry to the Ministry of Science and Technology.
05.26 /
Hanyi Biology was awarded the “License of Member Unit of Beijing Enterprise Science and Technology Association”.
06.13 /
HMI Group and Institute of Hemp, Chinese Academy of Agricultural Sciences signed a contract to conduct in-depth innovative cooperation on germplasm resources of industrial hemp.
06.30 /
Hanyi Biology has become Beijing Patent Pilot Unit, which closely combines the management of intellectual property rights with the development of enterprises.
07.14 /
HMI Group established the party branch of the Chinese Communist Party of China (CPC) and gave full play to the role of the party organization in the private enterprises, providing a steady stream of impetus for the development of enterprises.HMI Group Labor Union was established at the same time.
08.30 /
Hanyi Biology has launched China's full-range functional skin care products made of hemp: CANNACLEAR.
09.03 /
Mr. Tan Xin, Chairman of HMI Group, took a business trip to United States for business investigation and negotiation. He and Ms. Barbara Cegavske, the Secretary General of Nevada, together with Mr. David Mckeon, the US Congressional candidate, agreed to work on establishing an overseas cannabis plantation base.
09.15 /
HMI Group has been invited by Hainan Provincial Government to negotiate setting up a "Special Town of Hanma Medical Care and Nursing".
09.27 /
Mr. Tan Xin, Chairman of HMI Group, was selected as Part of the 2017 Kunming High-level Talent Introduction Project.HMI Group, Milan University of Technology and Beijing International Design Week jointly promoted the development of maternal and infant products made from industrial hemp.
11.07 /
HMI Group and BlueSky co. LTD of Canada jointly established Hemp BlueSky co., LTD. to fully enter pet products and pet health care products market in China, Canada, Australia and US.
11.09 /
Mr. Tan Xin, Chairman of HMI Group, visited US to negotiate with Nevada Republican Chairman Mr. Michael McDonald, congressional candidate Mr. James Comer and Nevada Deputy Governor Mr. Mark Hutchinson on the establishment of overseas extraction plants and industrial cooperation for industrial hemp.The Mexican Ambassador of the United States, on behalf of the Mexican President, invited Mr. Tan Xin to visit Mexico.
11.13 /
HMI Group established Hemp Fund Management co., LTD to invest in upstream and downstream enterprises of industrial use and medical use of hemp industry with great growth potential.
11.16 /
New product "Aima Power" hemp beverage by Hanyi Biology held a global brand conference.
12.06 /
Hanyi Biology has been certified as a “National High-tech Enterprise”.
12.14 /
Hansu Biology has been recognized as a “Small and Medium-sized Scientific Enterprise” in Yunnan Province.
12.25 /
HSuma Biology was approved to be issued “Yunnan Province Industrial Hemp Planting License”.
02.07 /
HMI Group and Yunnan Yuxi Government signed a formal cooperation contract.
02.10 /
HMI Group and Yu Ye Group has reached strategic cooperation.HMI Group has formally taken a stake in Hong Kong-listed Merui Health International co., LTD (HK2327).
02.13 /
HMI Group and Mr. Zhu Ye, Chairman of Tianshen Entertainment co., LTD (002354) signed a contract to establish Beijing Jianma Technology co., LTD.
03.15 /
The standardized medical cannabis extraction plant invested by hemp capital and technology of HMI Group, broke ground in Carlisle County in the state of Kentucky U.S.As the largest shareholder, HMI Group will continue to promote the global development of cannabis bio-pharmaceutical and health concepts.
04.03 /
The Serbian Ambassador to China signed a comprehensive strategic cooperation agreement with HMI Group. The President of Serbia invited HMI Group to bring technology and industry to Serbia along with China's "One Belt, One Road" development and promised generous policy support to help HMI Group spread products through Europe.
06.06 /
Hansu Biology was successfully selected into the fifth batch of National Science and Technology SMES (Small and Medium-size Enterprise) in Yunnan Province in 2018.
06.12 /
HMI Group was invited to participate in the “2018 Shanghai International Indoor Plant Factory Seminar” to explore the industrialization application mode and approach of closed plant factory together with domestic and foreign experts, scholars and industry leaders.
06.14 /
HMI Group was invited to participate in the "5th China-South Asia Expo and the 25th China-Kunming Import and Export Fair" to jointly promote the prosperity of global hemp pharmaceutical industry.
09.23/
As the co-initiators of the brand alliance, HMI Group and its subordinate Hantong New Material Technology Development Co., Ltd participated in the prize presentation ceremony of "24 Solar Terms" creative product design winners & the new product release conference in Beijing international design week 2018, and their designs awarded a Gold Medal.
10.11/
Steve Sisolak, the governor of Nevada, United States, cordially met with Peter Tan, chairman of HMI Group. He hopes that HMI Group will bring China's industrial hemp achievements into the United States. At the same time, he hopes to promote US pharmaceutical and health products into the huge Chinese market, and granted all the policy license resources needed by HMI Group.
10.23 /
Winston Kan (Commercial counselor of the Canadian embassy & director of Alberta government Beijing office) his party three visited HMI group and met with Peter Tan (Chairman of HMI). The two sides had an in-depth discussion and exchange about the international situation of industry hemp. HMI was invited to participate in the investment and promote the development of Canada industrial hemp industry. At the same time, Canada government invites Peter Tan to visit Canada and promote the development of hemp industry of Canada and China.
10.28 /
HMI Group was invited to participate in “Hemp Research Institute Academic Exchange Meeting for 60th Anniversary Economic Crops Development Strategy in South of China” to demonstrate the stage achievements made by the both sides in the construction of industrial hemp gene pool and the excavation, protection and utilization of excellent resources of high phenolic components.
11.14 /
HMI Group has passed the ISO9001 quality management system certification taken a big step forward in the internationalization, high standardization and continuous improvement development.
11.14 /
Yunnan Hansu Biotechnology Co.,Ltd has been recognized as a Provincial HI-tech enterprise by Yunnan Province which is the enterprise of industrial hemp. That indicates National recognition the R&D capacity and technological innovation of Hansu on industrial hemp.
12.29 /
Institute of Chinese Academy of Agricultural Sciences on Hemp and HMI Group jointly declared two new industrial hemp products of comprehensive application, and obtained the identification and registration certificate of non-major crop varieties(NO.1809002& NO.1809003).
01.12 /
HMI Group and OIYOO jointly introduced hemp fiber into the field of women's health care, and launched a series of high-end products such as hemp clean face towel and hemp sanitary napkin.
02.11 /
Hansu CBD extract technology authorized Patent by the United States. The Patent is the international patent for medical extraction of cannabinoid in China (METHOD FOR EXTRACTION CANNABIDIOL FROM CANNABI).Hansu CBD application for drug master document has also been approved by FDA, becoming the Chinese manufacturer with DMF.
02.20 /
HMI Group/Meirui Health (02327.HK) jointly hosted the "Industrial hemp Industry Sharing Meeting and Meirui Health International Investor Exchange Meeting" in Beijing, attracting nearly 200 related people from well-known companies and investment institutions in the industry to attend the meeting.
02.26 /
HSBT entered into a four-party cooperation agreement with Shenzhen Zhuoli Energy Electronics Co., Ltd., Chen Jiamin and Zou Shulin to set up a joint venture company in Shenzhen to develop the research, development and sales of industrial hemp extract atomized liquid (tobacco oil) and its innovative application in medical treatment (inhalation administration).
03.11 /
HSBT signed the Framework Agreement on Equity Transfer and Capital Increase with Chengzhi Shares, Yiwu Hanmeng and Huade Fund to promote and complete the internal equity integration of Yunnan Hanmeng and Yunnan Hanpu.
03.28 /
SMBT and Erkang Pharmaceutical signed the Cooperation Intention Agreement, transferring no more than 10% equity.
04.03 /
SMBT signed the Cooperation Agreement with Huaren Pharmaceutical Co., Ltd., and jointly funded the establishment of a joint venture company. Relying on SMBT's technical and resource advantages in industrial HMI breeding and greenhouse planting, it will build an industrial HMI green factory in Yunnan.
04.09 /
HYBT and Dezhan Healthcare jointly established Deyi Pharmaceutical Co., Ltd. to promote the application of cannabidiol in the treatment of rare diseases, cancer and other major diseases that seriously affect human health.
04.17 /
HMI Group signed the Joint Venture Agreement with Cross-border Tongbao E-commerce Co., Ltd. and Guangdong Yingruixing Asset Management Co., Ltd., and jointly invested in the establishment of Shenzhen Huanyu Hemp E-commerce Co., Ltd. to build the world's cross-border e-commerce platform for industrial hemp related products.
04.24 /
HMI Group officially signed a cooperation agreement with ACGT, a listed company in Canada, and appointed HSBT to participate in ACGT, holding 35% shares of ACGT, becoming the largest shareholder of ACGT. During the year, it will build an extraction base in Canada, focusing on expanding cannabidiol extraction business and market in North America and Europe.
04.24 /
Malaysia's Minister of International Trade and Industry and a delegation of more than ten people visited HMI Group. HMI Group will serve as the international consultant of the Malaysian government on industrial Hemp industry, and provide advice and suggestions for the promotion of local legislation on industrial Hemp industry in Malaysia.
05.20 /
The Brand Launch Conference of Jianma Biotechnology "Chaowu Chaowu", a subsidiary of HMI Group, was held in Beijing. The world's mirror electronic cigarette, the pure natural PD smoky oil brand iLAX in China and the independent smoky oil brand iOil were born.
05.21 /
HMI Group and Shenzhen Datong plan to jointly establish a joint venture company (HMI Group holds 40% of the shares). The main investment directions are: the traceability application of blockchain in the whole industrial chain of industrial hemp, the construction of CBD extraction factory, the cultivation of industrial hemp, the whole industry consolidation and expansion of industrial hemp, the research and development, production and domestic and overseas sales of hemp-based biopharmaceutical products.
06.18 /
HSBT was invited to participate in the 19th World Raw Materials China Exhibition, which attracted the attention of domestic and foreign buyers and the media, and attracted many interested partners.
07.22 /
Yunnan Provincial Department of Industry released the list of 100 Private Small Giant Enterprises to be determined in Yunnan in 2019, and HSBT, a subsidiary of HMI Group, was on the list. Since then, HSBT has once again been rated as a Provincial-level Growth-oriented Small and Medium-sized Enterprise in Yunnan Province and a star enterprise in Xingchuang Tiandi.
07.27 /
China Science and Technology Industry Parent Fund with a total scale of 100 billion was launched in Beijing, and Hanma Group participated in the establishment of the fund. Chairman Tan Xin and many business leaders attended the launching ceremony of "2019 China Parent Fund Summit" and jointly launched China Science and Technology Industry Parent Fund.
08.04 /
HSBT a subsidiary of Hemp Group, was invited to participate in the National CBD (Cannabidiol) Expo-Miami CBD Expo as the world's large scale CBD extraction and separation base and exporter of hemp-based pharmaceutical raw materials.
08.09 /
HMI Group (Kunming) Technology Center was established to deepen the strategic layout of "patent pool".
08.30 /
HMI Group and A-share listed company Yi Shida signed the Cooperation Framework Agreement on "Jointly Building the Production and Processing Project of Industrial Hemp Base Materials, Incense Chips and Their Products", and committed to building the world's industrial hemp base materials+cannabinoids+low-temperature incombustible cigarette bomb production base.
09.05 /
HMI Group signed a strategic cooperation agreement with Kunming Agricultural Investment and Yunnan Agricultural University, and formally established a cooperative relationship: HMI Group and Kunming Agricultural Investment will conduct in-depth cooperation in industrial hemp industry chain development through capital cooperation and relying on the scientific research advantages of Yunnan Agricultural University.
09.11 /
Thanks to the high-tech achievement transformation of "Preparation of Water-Soluble Cannabidiol and Study on Bioutilization Effect", HSBT successfully broke through the industry barriers and won the prize of Growth Group.
11.11 /
Xiwu Technology, a subsidiary of HMI Group, held the "New Product Launch Conference of Xiwu Technology 2019" in Shenzhen, and its digital new channel system was officially unveiled, which will bring new gameplay to the e-cigarette industry.
11.19 /
Mr. Tan Xin, Chairman of HMI Group, was invited to attend the "2019 Global (China-Myanmar) Industrial Hemp Industry Development Ecological Conference" held in Ruili, where he delivered a keynote speech titled "Industrial Hemp Industry Chain Opportunity" and put forward constructive opinions and suggestions for the development of China and Myanmar.
11.22 /
Hong Kong listed company Xiong 'an Technology (01647.HK) announced that it has entered into a framework agreement with HMI Group and SMBT, and plans to issue shares to HMI Group to acquire 51% equity of SMBT, a subsidiary of HMI Group, and HMI Group will become the major shareholder of the listed company.
12.11 /
HSBT, a subsidiary of HMI Group, was invited to participate in "MJBizCon HMI Business Exhibition" on December 12, 2019 as a large-scale CBD extraction and separation base and an exporter of hemp-based medical raw materials.
12.12 /
Academician Yang Baofeng of HYBT logy, a subsidiary of HYBT, was rated as excellent by Beijing Science and Technology Association in the assessment of "2019 Beijing Academician Expert Workstation".
03.24 /
The headquarters of HMI Group held an exchange meeting with the theme of "Playing with the digital system, subverting the traditional marketing model, and socializing the new retail model of all partners in Xiwu".
03.30 /
HMI Group and affiliated institutions of Chinese Academy of Agricultural Sciences transferred a high-content industrial Hemp seed resource to enhance the international competitive advantage of Chinese industrial Hemp enterprises.
04.20 /
HMI Group established a partnership and signed an investment agreement with Geyser Brands Inc, a fully licensed cannabis company.
04.30 /
Academician HYBT Expert Workstation, Fighting "Epidemic Disease" Together.
05.08 /
Tan Xin, chairman of HMI Group, attended the online live broadcast summit of industrial HMI and proposed that the investment of industrial HMI should follow the "cocoon breaking investment rule", and "industrial Hemp plus" may be the benchmark of "internet plus".
06.08 /
Xisu CISOO, an e-cigarette brand owned by HMI Group, released 19.9 yuan for new products, and spent 200 million yuan to subsidize users and channels.
06.24 /
The legalization of industrial cannabis is in sight, and the industry and capital gather in HMI Group to join hands with Dezhan Healthcare to share the policy dividend.
09.10 /
Tan Xin, chairman of HMI Group, attended the China Hemp Industry Application Forum in 2020 and accepted an online interview with Xinma. He put forward that the core of Hemp Industry application is biopharmaceuticals and new rules for grasping new trends.
10.10 /
The "Expert Appraisal Meeting of New Industrial HMI Variety Zhonghanma Series" was successfully held, and Zhonghanma No.2, Zhonghanma No.3 and Zhonghanma No.4 successfully became high-quality germplasm resources of Zhonghanma through expert appraisal.
12.25 /
Hanyi Biotechnology (Beijing) Co., Ltd., a wholly-owned subsidiary of HMI Group, signed the Strategic Cooperation Framework Agreement with Tsinghua University Cross-Strait Development Research Institute. With the advantages of resources in their respective fields, the two sides have carried out comprehensive and in-depth cooperation in biomedical fields such as medicinal research of new compounds and development of new drugs.
02.07 /
At present, the batch of patrol vehicles in the "Sanjiangyuan Guardian Project" project have been handed over, and these vehicles were jointly donated by HMI Group and Beijing Water Conservation Foundation.
04.26 /
Cheng Lianyuan, member of the Standing Committee of Yunnan Provincial Party Committee and Secretary of Kunming Municipal Party Committee, Xia Junsong, member of the Standing Committee of Yunnan Municipal Party Committee and Secretary General of Kunming Municipal Party Committee, Zhang Bin, member of the Standing Committee of Yunnan Municipal Party Committee and executive deputy mayor, and other eight people visited HMI Group for inspection and guidance.
04.27 /
Deyi Pharmaceutical, a joint venture company established by HYBT, a subsidiary of HYBT, and Dezhan Healthcare (000813), has obtained overseas Japanese authorization for the application patent of cannabidiol CBD in pulmonary hypertension.
05.17 /
The patent of "application of cannabidiol in preparation of drugs for treating pulmonary hypertension" applied by Deyi Pharmaceutical, a joint venture company established by HYBT, a subsidiary of HYBT, and Dezhan Healthcare (000813), was officially granted in China.
05.26/
HMI group cannabidiol CBD anti-influenza virus patent domestic invention has been authorized.
04.01 /
Two PCT international applications led by HYBT -R&D Team under HMI Group were authorized in Europe. Use of cannabidiol in preparing anti-influenza medicine, a composition containing cannabidiol and/or hypocannabidiol and its application in treating dysmenorrhea. Up to now, HMI Group has obtained six PCT international patents for biomedicine.
